Oxyfedrine

This classification denotes a vasodilating agent and beta-adrenergic agonist with the molecular formula C19H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DWL616XF1K, chemically known as 3-(((alphas,betar)-beta-hydroxy-alpha-methylphenethyl)amino)-3-methoxypropiophenone but generally known as oxyfedrine, which bears US NIH Compound Identifier 27454. European Medicines Agency schedules Oxyfedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09564MIG. The term OXYFEDRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules oxyfedrine in its Anatomical Therapeutic Chemical (ATC) Classification. OXYFEDRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxyfedrine under HS 29225000 and SITC 51467. As of Q4 2014, OXYFEDRINE remains the US FDA Preferred Term for this commodity. Oxyfedrine bears US NLM identifiers UMLS ID C0030053 and NCI Concept Code C74199. SMILES: OC(C(NCCC(=O)c1cc(OC)ccc1)C)c1ccccc1.